| Filed On | Filing |
|---|---|
| 30 Dec 2024 | 15-12G |
| 18 Dec 2024 |
Form 4: Gennadios Aristippos, Group Pres. Pharma & Consumer
Returned 135,286 shares to the issuer · Received 21,562 shares as a grant or award |
| 18 Dec 2024 |
Form 4: McErlane David, Group President, Biologics
Returned 47,730 shares to the issuer · Received 11,426 shares as a grant or award · Disposed of 14,740 Option to purchase Common Stock (Disposition to Issuer) |
| 18 Dec 2024 |
Form 4: Hatzfeld Michael, Chief Accounting Officer
Returned 16,676 shares to the issuer · Received 3,144 shares as a grant or award |
| 18 Dec 2024 |
Form 4: Gunther Scott, SVP, Quality & Reg. Affairs
Returned 52,573 shares to the issuer · Received 12,938 shares as a grant or award |
| 18 Dec 2024 |
Form 4: Ferraro Joseph Anthony, SVP, General Counsel, CCO
Returned 38,232 shares to the issuer · Received 14,265 shares as a grant or award |
| 18 Dec 2024 |
Form 4: Stahl Jack L, Director
Returned 47,984 shares to the issuer |
| 18 Dec 2024 |
Form 4: Ryan Michelle R, Director
Returned 10,835 shares to the issuer |
| 18 Dec 2024 |
Form 4: Okey Stephanie, Director
Returned 12,635 shares to the issuer |
| 18 Dec 2024 |
Form 4: Morel Donald E Jr, Director
Returned 70,118 shares to the issuer |
| 18 Dec 2024 |
Form 4: Lucier Gregory T, Director
Returned 36,914 shares to the issuer |
| 18 Dec 2024 |
Form 4: Damelio Frank A, Director
Returned 12,635 shares to the issuer |
| 18 Dec 2024 |
Form 4: Classon Rolf A, Director
Returned 47,984 shares to the issuer |
| 18 Dec 2024 |
Form 4: Carroll J Martin, Director
Returned 32,734 shares to the issuer |
| 18 Dec 2024 |
Form 4: Barg Steven, Director
Returned 12,374 shares to the issuer |
| 18 Dec 2024 |
Form 4: Barber Michael J, Director
Returned 18,052 shares to the issuer |
| 18 Dec 2024 |
Form 4: Maselli Alessandro, Director
Returned 290,745 shares to the issuer · Received 113,224 shares as a grant or award · Disposed of 224,476 Options to purchase Common Stock (Disposition to Issuer) |
| 18 Dec 2024 |
Form 4: Hopson Ricky, Pres. BioProduct Delivery, CoS
Returned 40,696 shares to the issuer · Received 10,722 shares as a grant or award · Disposed of 26,939 Options to purchase Common Stock (Disposition to Issuer) |
| 18 Dec 2024 |
Form 4: Masanovich Matti, SVP, Chief Financial Officer
Returned 148,166 shares to the issuer · Received 71,691 shares as a grant or award · Disposed of 81,082 Options to purchase Common Stock (Disposition to Issuer) |
| 18 Dec 2024 |
Form 4: Greisch John J, Director
Returned 147,462 shares to the issuer · Received 33,530 shares as a grant or award · Disposed of 127,096 Options to purchase Common Stock (Disposition to Issuer) |
Loading...
